154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis

BACKGROUND: Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development as a potential treatment for allergic rhinitis. The objective of this study was to determine the long-term safety and efficacy of CIC-HFA compared to placebo in subjects with perennial allergic rhinitis (PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, William, Mohar, Dale, Raphael, Gordon, LaForce, Craig, Huang, Holly, Desai, Shailesh, Bode, Frederick, Karafilidis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Abstracts of the XXII World Allergy Congress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512737/
http://dx.doi.org/10.1097/01.WOX.0000411911.97281.2a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512737/
http://dx.doi.org/10.1097/01.WOX.0000411911.97281.2a

Ejemplares similares